Abbott Laboratories first quarter profits eclipsed $2.4 billion thanks to a surge in sales of Covid-19 diagnostic tests, the company said April 20, 2022. In this photo, Abbott Chairman of the Board ...

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...

Abbott Laboratories (NYSE: ABT) is a leader in coronavirus testing. Its laboratory tests and rapid tests have brought in billions of dollars in revenue. In the fourth quarter of last year, for example ...

Abbott Laboratories reported organic sales growth of 35% in its diagnostics unit on the back of strong demand for COVID-19 testing, according to the company’s earnings report released Wednesday ...

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...

Abbott (NYSE: ABT) will report its Q2 2023 results on Thursday, July 20. We expect the company to post revenue and earnings in line with the street expectations. Abbott will see a decline in sales ...

By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott ...